Ventripoint Announces $500,000 Debenture Unit Private

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Ventripoint Announces $500,000 Debenture Unit Private Placement

SEATTLE, WASHINGTON--(Marketwired - Aug. 1, 2013) -

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE:VPT) (OTCQX:VPTDF) announces that it intends to complete a non-brokered private placement of up to CDN$500,000 (the "Offering") of debenture units of the Corporation at a price of $1,000 per unit ("Units"). The Units will be comprised of $1,000 principal amount of convertible non-secured debentures ("Debentures"), which shall mature three years from the date of issuance of the Debentures (the "Maturity Date") and 5,000 common share purchase warrants with an exercise price of $0.15 for a period of three years. Depending on market conditions, the Corporation reserves the right to increase the maximum gross proceeds under the Offering, subject to approval of the TSX Venture Exchange (the "Exchange"). The Debentures shall bear a 12% annual simple interest calculated on the principal amount, with any accrued but unpaid interest under the Debentures due and payable on the anniversary of the Debenture in either cash or Common Shares (at the option of the Corporation) with the number of Common Shares being determined by using the 10 day volume-weighted average price of the Common Shares on the Exchange on that date that is five days prior to the anniversary date (subject to the approval of the Exchange). The Debentures may be converted by the holder at any time following the date of issuance at a price of $0.10 per share and the Debentures may be repaid partially, or in full, by the Corporation to any or all of the subscribers at any time without penalty.

The Corporation intends to use the proceeds from the Offering to incur expenditures for: (i) product and service commercialization of the VMS; (ii) clinical validation of VMS functionality, including applications for additional diagnoses and heart diseases; and (iii) for general working capital purposes and potentially to repay debt and outstanding payables.

The Corporation may pay a commission or finder's fee of up to 7% cash and agent's options equal to up to 7% of the shares issuable upon exercise of the debentures. Each option will be exercisable at a price of $0.15 per Common Share for a period of 18 months from the date of issuance.

The Offering is subject to the approval of the Exchange. The securities will be subject to a four-month hold period, in accordance with applicable securities laws.

About Ventripoint Diagnostics Ltd.

Ventripoint has created diagnostic tools to monitor patients with heart disease, a leading cause of death in developed countries. VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The Corporation has a suite of applications for all major heart diseases and imaging modalities including congenital heart disease, left or right heart failure and normal hearts - a multi-billion dollar market potential. The VMS™ is for investigational use only in the United States and approved for clinical use in Canada and Europe.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

FORWARD-LOOKING STATEMENTS: This news release may contain certain forward-looking information and statements, including without limitation, statements pertaining to the closing of the Offering including the Corporation's ability to obtain necessary approvals from the TSX Venture Exchange. All statements, other than statements of historical facts, which address Ventripoint's expectations, should be considered forward-looking statements. Such statements are based on management's exercise of business judgment as well as assumptions made by and information currently available to management. When used in this document, the words "may", "will", "anticipate", "believe", "estimate", "expect", "intend" and words of similar import, are intended to identify any forward-looking statements. You should not place undue reliance on these forward-looking statements. These statements reflect a current view of future events and are subject to certain risks and uncertainties as contained in the Corporation's filings with Canadian securities regulatory authorities. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results could differ materially from those anticipated in these forward-looking statements. A description of assumptions used to develop such forward-looking information and a description of risk factors that may cause actual results to differ materially from forward-looking information can be found in Ventripoint's disclosure documents on the SEDAR website at www.sedar.com . The Corporation undertakes no obligation, and does not intend, to update, revise or otherwise publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof, or to reflect the occurrence of any unanticipated events. Although management believes that expectations are based on reasonable assumptions, no assurance can be given that these expectations will materialize.

Ventripoint Diagnostics Ltd. Dr. George Adams CEO (206) 910-9125 gadams@Ventripoint.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 0

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Zunyi’s History Tour Carries China’s Story Overseas

Updated Category News Views 46

China’s national story does not travel overseas by accident; it gets carried by visitors, monuments, rail lines, rivers and carefully chosen questions. The Zunyi News and Media Center report follows Tayyab, a Pakistani PhD student in aerospace engineering at Peking University, as he heads from Beijing to Zunyi, Guizhou, carrying a copy of Edgar Snow’s Red Star Over...

Continue Reading
Vertex Extends Genomics Pact With $220M in Potential

Updated Category News Views 49

Eight years is long enough to separate a useful science partner from a glossy slide deck, and Vertex’s decision to add four more years with Genomics deserves attention. This is not a splashy acquisition, nor is it a clean revenue number investors can plug into next quarter’s model. It is a deeper commitment to the slow, expensive, wonderfully unforgiving business of...

Continue Reading
Exiger's CEO Honored for Military Support Excellence

Updated Category News Views 118

Recognizing Civilian and Military Leadership When you hear "recognition in the military sector," it isn't just a pat on the back. It's a whole parade of brass hats and high-flyers giving their nods. So, November 10th wasn't just any regular day—Brandon Daniels, CEO of Exiger, gets a shiny, prestigious Five-Star Award for his "extraordinary support" of our military...

Continue Reading
Photocure Opens a New Access Route for Hexvix Patients

Updated Category News Views 25

Forty-plus markets just moved from “not available” toward a workable route for individual bladder cancer patients, and that is the real substance of Photocure’s new arrangement with Clinigen. This is not a sweeping product launch, nor is it an approval announcement dressed up in confetti. It is a Named Patient Program, which matters because the regulatory plumbing...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 171

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Unilumin's APEC 2026 Showcase Is a Useful Field Test

Updated Category News Views 65

Few sales pitches get stress-tested by a thousand journalists, a major airport, and a leaders' summit all at once. That is the useful part of Unilumin's role as an official sponsor of APEC 2026 in Shenzhen. The company says its LED systems were installed across summit venues, the media center, transportation hubs, and city landmarks as the 33rd APEC Economic Leaders'...

Continue Reading
CATL Makes Its APEC Case Beyond the Electric Car Market

Updated Category News Views 10

A 99-Second Pitch With Bigger Ambitions Battery swapping got a rare moment in the geopolitical sunlight at Shenzhen's APEC CEO Summit, and CATL was plainly trying to make that moment count. Dr. Robin Zeng, the company's founder, chairman and chief executive, used the opening business dialogue to argue that the Asia-Pacific region holds more opportunity than trouble. Fair...

Continue Reading
Diwali at Heritage Shows the Real Estate Community Test

Updated Category News Views 89

Fireworks do not sell a townhome by themselves, but belonging can sure help close the distance between a brochure and a serious purchase. Heritage at South Brunswick recently held a Diwali celebration sponsored by American Properties at South Brunswick LLC, bringing homeowners, families, and the builder's team into the same room for an evening of food, music, dancing,...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 321

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading

Top 5 Most Recently Viewed Articles

Future Prospects of the Aluminum Die Casting Machine Market

Updated Category News Views 293

Growing Demand for Aluminum Die Casting Machines The Aluminum Die Casting Machine market is set to experience notable growth, with expectations to reach a significant market value of around $4.2 billion soon. Projections indicate that this sector could expand at a compound annual growth rate (CAGR) of 6.5% over the upcoming years, potentially hitting approximately $7.3...

Continue Reading
Upcoming Class Action Against Match Group, Inc. (MTCH)

Updated Category News Views 160

Upcoming Class Action Against Match Group, Inc. (MTCH) The Gross Law Firm recently announced a class action notice aimed at shareholders of Match Group, Inc. (NASDAQ: MTCH). This notice serves as an important call to action for shareholders who purchased shares during a specified class period. The firm encourages these individuals to reach out regarding their potential...

Continue Reading
Unveiling Hidden Treasures of Giza at Cosmic Summit 2025

Updated Category News Views 589

Unveiling Hidden Treasures of Giza at Cosmic Summit 2025 Get ready for an exciting event that promises to shed light on groundbreaking findings beneath the iconic Pyramids of Giza! The Cosmic Summit 2025 presents an exclusive opportunity for journalists to engage with distinguished researchers from the Khafre Research Project. Their innovative use of acoustic and radar...

Continue Reading
Impacts of Recent Class Action on WPP plc Investors' Rights

Updated Category News Views 251

Understanding the Class Action Against WPP plc Recently, a significant class action lawsuit has been initiated against WPP plc (NYSE: WPP), raising important issues for its shareholders. The accusations suggest that the company's leadership misrepresented the reliability of its revenue forecasts and growth potential, all while downplaying risks associated with...

Continue Reading
Texaf Secures EUR 5.39 Million for Sustainable Development

Updated Category News Views 47

Texaf's Strategic Development in Urban Infrastructure Texaf is taking significant strides in urban development with its recent project, the Petit-Pont building. The company is set to benefit from a substantial investment of EUR 5.39 million coming from the SFA Congo and African Rivers Fund IV LP. This initiative not only reflects Texaf's commitment to enhancing...

Continue Reading